CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 2 filers reported holding CUBIST PHARMACEUTICALS INC in Q1 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $113,000 | +63.8% | 1,120 | +12.0% | 0.00% | +50.0% |
| Q4 2013 | $69,000 | +7.8% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $64,000 | +33.3% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $48,000 | +2.1% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $47,000 | +11.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2012 | $42,000 | +950.0% | 1,000 | +834.6% | 0.00% | – |
| Q4 2011 | $4,000 | -92.0% | 107 | -94.6% | 0.00% | -100.0% |
| Q1 2011 | $50,000 | +16.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2010 | $43,000 | -8.5% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2010 | $47,000 | +14.6% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2010 | $41,000 | -8.9% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2010 | $45,000 | -21.1% | 2,000 | -33.3% | 0.00% | 0.0% |
| Q4 2009 | $57,000 | -6.6% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q3 2009 | $61,000 | +10.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2009 | $55,000 | +12.2% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2009 | $49,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AKANTHOS CAPITAL MANAGEMENT LLC | 50,500 | $3,526,000 | 10.49% |
| Palo Alto Investors LP | 1,526,916 | $106,609,000 | 7.94% |
| HealthCor Management, L.P. | 1,225,000 | $85,530,000 | 4.29% |
| SECTOR GAMMA AS | 192,490 | $13,440,000 | 3.18% |
| AMI ASSET MANAGEMENT CORP | 363,698 | $25,393,000 | 2.52% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 578,207 | $40,370,000 | 2.01% |
| TURNER INVESTMENTS LLC | 559,239 | $39,046,000 | 1.73% |
| Tekla Capital Management LLC | 263,772 | $18,417,000 | 1.69% |
| MAZAMA CAPITAL MANAGEMENT INC | 80,221 | $5,601,000 | 1.50% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,234,570 | $225,838,000 | 1.34% |